Serum microRNAs are early indicators of survival after radiation-induced hematopoietic injury

Accidental radiation exposure is a threat to human health that necessitates effective clinical planning and diagnosis. Minimally invasive biomarkers that can predict long-term radiation injury are urgently needed for optimal management after a radiation accident. We have identified serum microRNA (m...

Full description

Saved in:

Bibliographic Details
Published in:	Science translational medicine Vol. 7; no. 287; p. 287ra69
Main Authors:	Acharya, Sanket S, Fendler, Wojciech, Watson, Jacqueline, Hamilton, Abigail, Pan, Yunfeng, Gaudiano, Emily, Moskwa, Patryk, Bhanja, Payel, Saha, Subhrajit, Guha, Chandan, Parmar, Kalindi, Chowdhury, Dipanjan
Format:	Journal Article
Language:	English
Published:	United States 13.05.2015
Subjects:	Animals Biomarkers - blood Gene Expression Profiling Hematopoietic Stem Cells - radiation effects Humans Male Mice Mice, Inbred C57BL MicroRNAs - blood MicroRNAs - genetics Whole-Body Irradiation
ISSN:	1946-6242, 1946-6242
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	Accidental radiation exposure is a threat to human health that necessitates effective clinical planning and diagnosis. Minimally invasive biomarkers that can predict long-term radiation injury are urgently needed for optimal management after a radiation accident. We have identified serum microRNA (miRNA) signatures that indicate long-term impact of total body irradiation (TBI) in mice when measured within 24 hours of exposure. Impact of TBI on the hematopoietic system was systematically assessed to determine a correlation of residual hematopoietic stem cells (HSCs) with increasing doses of radiation. Serum miRNA signatures distinguished untreated mice from animals exposed to radiation and correlated with the impact of radiation on HSCs. Mice exposed to sublethal (6.5 Gy) and lethal (8 Gy) doses of radiation were indistinguishable for 3 to 4 weeks after exposure. A serum miRNA signature detectable 24 hours after radiation exposure consistently segregated these two cohorts. Furthermore, using either a radioprotective agent before, or radiation mitigation after, lethal radiation, we determined that the serum miRNA signature correlated with the impact of radiation on animal health rather than the radiation dose. Last, using humanized mice that had been engrafted with human CD34(+) HSCs, we determined that the serum miRNA signature indicated radiation-induced injury to the human bone marrow cells. Our data suggest that serum miRNAs can serve as functional dosimeters of radiation, representing a potential breakthrough in early assessment of radiation-induced hematopoietic damage and timely use of medical countermeasures to mitigate the long-term impact of radiation.
AbstractList	Accidental radiation exposure is a threat to human health that necessitates effective clinical planning and diagnosis. Minimally invasive biomarkers that can predict long-term radiation injury are urgently needed for optimal management after a radiation accident. We have identified serum microRNA (miRNA) signatures that indicate long-term impact of total body irradiation (TBI) in mice when measured within 24 hours of exposure. Impact of TBI on the hematopoietic system was systematically assessed to determine a correlation of residual hematopoietic stem cells (HSCs) with increasing doses of radiation. Serum miRNA signatures distinguished untreated mice from animals exposed to radiation and correlated with the impact of radiation on HSCs. Mice exposed to sublethal (6.5 Gy) and lethal (8 Gy) doses of radiation were indistinguishable for 3 to 4 weeks after exposure. A serum miRNA signature detectable 24 hours after radiation exposure consistently segregated these two cohorts. Furthermore, using either a radioprotective agent before, or radiation mitigation after, lethal radiation, we determined that the serum miRNA signature correlated with the impact of radiation on animal health rather than the radiation dose. Last, using humanized mice that had been engrafted with human CD34(+) HSCs, we determined that the serum miRNA signature indicated radiation-induced injury to the human bone marrow cells. Our data suggest that serum miRNAs can serve as functional dosimeters of radiation, representing a potential breakthrough in early assessment of radiation-induced hematopoietic damage and timely use of medical countermeasures to mitigate the long-term impact of radiation. Accidental radiation exposure is a threat to human health that necessitates effective clinical planning and diagnosis. Minimally invasive biomarkers that can predict long-term radiation injury are urgently needed for optimal management after a radiation accident. We have identified serum microRNA (miRNA) signatures that indicate long-term impact of total body irradiation (TBI) in mice when measured within 24 hours of exposure. Impact of TBI on the hematopoietic system was systematically assessed to determine a correlation of residual hematopoietic stem cells (HSCs) with increasing doses of radiation. Serum miRNA signatures distinguished untreated mice from animals exposed to radiation and correlated with the impact of radiation on HSCs. Mice exposed to sublethal (6.5 Gy) and lethal (8 Gy) doses of radiation were indistinguishable for 3 to 4 weeks after exposure. A serum miRNA signature detectable 24 hours after radiation exposure consistently segregated these two cohorts. Furthermore, using either a radioprotective agent before, or radiation mitigation after, lethal radiation, we determined that the serum miRNA signature correlated with the impact of radiation on animal health rather than the radiation dose. Last, using humanized mice that had been engrafted with human CD34(+) HSCs, we determined that the serum miRNA signature indicated radiation-induced injury to the human bone marrow cells. Our data suggest that serum miRNAs can serve as functional dosimeters of radiation, representing a potential breakthrough in early assessment of radiation-induced hematopoietic damage and timely use of medical countermeasures to mitigate the long-term impact of radiation.Accidental radiation exposure is a threat to human health that necessitates effective clinical planning and diagnosis. Minimally invasive biomarkers that can predict long-term radiation injury are urgently needed for optimal management after a radiation accident. We have identified serum microRNA (miRNA) signatures that indicate long-term impact of total body irradiation (TBI) in mice when measured within 24 hours of exposure. Impact of TBI on the hematopoietic system was systematically assessed to determine a correlation of residual hematopoietic stem cells (HSCs) with increasing doses of radiation. Serum miRNA signatures distinguished untreated mice from animals exposed to radiation and correlated with the impact of radiation on HSCs. Mice exposed to sublethal (6.5 Gy) and lethal (8 Gy) doses of radiation were indistinguishable for 3 to 4 weeks after exposure. A serum miRNA signature detectable 24 hours after radiation exposure consistently segregated these two cohorts. Furthermore, using either a radioprotective agent before, or radiation mitigation after, lethal radiation, we determined that the serum miRNA signature correlated with the impact of radiation on animal health rather than the radiation dose. Last, using humanized mice that had been engrafted with human CD34(+) HSCs, we determined that the serum miRNA signature indicated radiation-induced injury to the human bone marrow cells. Our data suggest that serum miRNAs can serve as functional dosimeters of radiation, representing a potential breakthrough in early assessment of radiation-induced hematopoietic damage and timely use of medical countermeasures to mitigate the long-term impact of radiation.
Author	Fendler, Wojciech Acharya, Sanket S Bhanja, Payel Watson, Jacqueline Guha, Chandan Chowdhury, Dipanjan Parmar, Kalindi Hamilton, Abigail Gaudiano, Emily Pan, Yunfeng Moskwa, Patryk Saha, Subhrajit
Author_xml	– sequence: 1 givenname: Sanket S surname: Acharya fullname: Acharya, Sanket S organization: Department of Radiation Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA 02215, USA – sequence: 2 givenname: Wojciech surname: Fendler fullname: Fendler, Wojciech organization: Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Lodz 91-738, Poland – sequence: 3 givenname: Jacqueline surname: Watson fullname: Watson, Jacqueline organization: Department of Radiation Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA 02215, USA – sequence: 4 givenname: Abigail surname: Hamilton fullname: Hamilton, Abigail organization: Department of Radiation Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA 02215, USA – sequence: 5 givenname: Yunfeng surname: Pan fullname: Pan, Yunfeng organization: Department of Radiation Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA 02215, USA – sequence: 6 givenname: Emily surname: Gaudiano fullname: Gaudiano, Emily organization: Department of Radiation Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA 02215, USA – sequence: 7 givenname: Patryk surname: Moskwa fullname: Moskwa, Patryk organization: Department of Internal Medicine A, Medical University of Greifswald, Ferdinand-Sauerbruchstrasse, Greifswald 17475, Germany – sequence: 8 givenname: Payel surname: Bhanja fullname: Bhanja, Payel organization: Department of Radiation Oncology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY 10461, USA – sequence: 9 givenname: Subhrajit surname: Saha fullname: Saha, Subhrajit organization: Department of Radiation Oncology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY 10461, USA – sequence: 10 givenname: Chandan surname: Guha fullname: Guha, Chandan organization: Department of Radiation Oncology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY 10461, USA. Department of Pathology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY 10461, USA – sequence: 11 givenname: Kalindi surname: Parmar fullname: Parmar, Kalindi organization: Department of Radiation Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA 02215, USA – sequence: 12 givenname: Dipanjan surname: Chowdhury fullname: Chowdhury, Dipanjan email: dipanjan_chowdhury@dfci.harvard.edu organization: Department of Radiation Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA 02215, USA. dipanjan_chowdhury@dfci.harvard.edu
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/25972001$$D View this record in MEDLINE/PubMed
BookMark	eNpNkEtLxDAUhYOMOA_9ByJZuumYpG2mWQ6DLxgUfCyl3CS3mKFtxiQdmH9vQQVX5yy-cxbfnEx63yMhl5wtORfyJhqXAvSx7dAuAUCWKj8hM64KmUlRiMm_PiXzGHeMySov5RmZilKtBGN8Rj5eMQwd7ZwJ_uVpHSkEpAihPVLXW2cg-RCpb2gcwsEdoKXQJAw0gHWQnO-zERsMWvqJ3QjvvcPkzDjeDeF4Tk4baCNe_OaCvN_dvm0esu3z_eNmvc1MsSpSZkrdVIYLkwsGjImGWbRc54VWhkvBV2C0zbWyoLEoldaGm0JYZUshUVUgFuT653cf_NeAMdWdiwbbFnr0Q6y5rEZlXCo5ole_6KBHc_U-uA7Csf5TIr4BOQFq0Q
CitedBy_id	crossref_primary_10_1080_09553002_2023_2214205 crossref_primary_10_1186_s40364_024_00585_x crossref_primary_10_1371_journal_pone_0329737 crossref_primary_10_1016_j_dnarep_2021_103245 crossref_primary_10_1177_1559325820926735 crossref_primary_10_1038_s41598_021_89682_7 crossref_primary_10_3389_fcell_2022_861451 crossref_primary_10_1016_j_toxlet_2024_07_911 crossref_primary_10_1038_s41598_023_45250_9 crossref_primary_10_3390_ijms222413476 crossref_primary_10_1182_bloodadvances_2022009249 crossref_primary_10_3389_fimmu_2024_1353990 crossref_primary_10_1371_journal_pone_0311379 crossref_primary_10_1140_epjs_s11734_025_01475_5 crossref_primary_10_3390_ijms25158446 crossref_primary_10_3390_cancers17111801 crossref_primary_10_3390_genes13020208 crossref_primary_10_1007_s00125_016_3945_0 crossref_primary_10_1136_heartasia_2018_011134 crossref_primary_10_1667_RADE_24_00275_1 crossref_primary_10_1016_j_bbrc_2022_02_010 crossref_primary_10_1667_RADE_23_00007_1 crossref_primary_10_1667_RR14702_1 crossref_primary_10_1096_fj_201802639R crossref_primary_10_1080_09553002_2021_1987562 crossref_primary_10_1080_1354750X_2018_1479771 crossref_primary_10_3390_app11073174 crossref_primary_10_1016_j_omtn_2022_11_010 crossref_primary_10_1155_2019_3010342 crossref_primary_10_1667_RADE_21_00187_1 crossref_primary_10_1177_15593258221123679 crossref_primary_10_1186_s13287_016_0464_3 crossref_primary_10_1002_jcla_23058 crossref_primary_10_1186_s40779_019_0203_z crossref_primary_10_3389_fmolb_2021_630718 crossref_primary_10_1140_epjp_s13360_021_01447_3 crossref_primary_10_3390_biom13050837 crossref_primary_10_1016_j_bbagrm_2017_08_006 crossref_primary_10_1016_j_ijrobp_2019_10_028 crossref_primary_10_1016_j_trsl_2018_06_001 crossref_primary_10_1038_s41598_018_19763_7 crossref_primary_10_1158_1078_0432_CCR_20_0572 crossref_primary_10_1080_09553002_2021_1928784 crossref_primary_10_1039_D4SD00079J crossref_primary_10_1371_journal_pone_0191402 crossref_primary_10_1080_14737159_2017_1366316 crossref_primary_10_1016_j_radonc_2023_109731 crossref_primary_10_1126_scitranslmed_aal2408 crossref_primary_10_1186_s12864_018_4884_6 crossref_primary_10_1016_j_trsl_2021_02_005 crossref_primary_10_1126_scitranslmed_aaw5831 crossref_primary_10_1093_clinchem_hvz034 crossref_primary_10_1038_s41598_021_85394_0 crossref_primary_10_2174_0929867327666200121122910 crossref_primary_10_1038_s41598_020_62255_w crossref_primary_10_1186_s12964_024_01959_2 crossref_primary_10_1667_RADE_21_000103_1 crossref_primary_10_1177_15593258221086478 crossref_primary_10_1667_RADE_23_00125_1 crossref_primary_10_1007_s11356_021_12509_5 crossref_primary_10_1080_1354750X_2018_1423707 crossref_primary_10_1002_adhm_202001615 crossref_primary_10_1016_j_molmed_2019_09_007 crossref_primary_10_1667_RR14452_1 crossref_primary_10_1667_RR14248_1 crossref_primary_10_1016_j_ijrobp_2021_10_150 crossref_primary_10_1586_14737159_2016_1121102 crossref_primary_10_1093_eurheartj_ehw206 crossref_primary_10_1007_s10585_025_10364_z crossref_primary_10_1111_pedi_12783 crossref_primary_10_1016_j_actaastro_2018_07_038 crossref_primary_10_3390_biomedicines8110461 crossref_primary_10_1134_S1022795424701102 crossref_primary_10_1371_journal_pone_0167333 crossref_primary_10_1007_s12010_024_05022_1 crossref_primary_10_1038_s41598_024_52258_2 crossref_primary_10_1080_09553002_2019_1569771
ContentType	Journal Article
Copyright	Copyright © 2015, American Association for the Advancement of Science.
Copyright_xml	– notice: Copyright © 2015, American Association for the Advancement of Science.
DBID	CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1126/scitranslmed.aaa6593
DatabaseName	Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	no_fulltext_linktorsrc
Discipline	Medicine
EISSN	1946-6242
ExternalDocumentID	25972001
Genre	Journal Article Research Support, N.I.H., Extramural
GrantInformation_xml	– fundername: NIAID NIH HHS grantid: R01 AI101897-01 – fundername: NIAID NIH HHS grantid: R01 AI101897 – fundername: NIAID NIH HHS grantid: 1U19AI091175-05 – fundername: NIAID NIH HHS grantid: U19 AI091175
GroupedDBID	--- 0R~ 4.4 53G 7~K ABJNI ACGFS AENEX AJGZS AJWWR ALMA_UNASSIGNED_HOLDINGS BKF C45 CGR CUY CVF DU5 EBS ECM EIF EJD EMOBN F5P HZ~ NPM O9- OFXIZ OVD OVIDX P2P RHI TEORI 7X8
ID	FETCH-LOGICAL-c474t-c5bf8c12c320a002f0ded1b34b9c16217acbd3b9dabe459bbc1c42d9d526e98a2
IEDL.DBID	7X8
ISICitedReferencesCount	82
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000354433900003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1946-6242
IngestDate	Fri Sep 05 12:48:02 EDT 2025 Thu Jan 02 22:19:36 EST 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	287
Language	English
License	Copyright © 2015, American Association for the Advancement of Science.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c474t-c5bf8c12c320a002f0ded1b34b9c16217acbd3b9dabe459bbc1c42d9d526e98a2
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
OpenAccessLink	http://doi.org/10.1126/scitranslmed.aaa6593
PMID	25972001
PQID	1681261696
PQPubID	23479
ParticipantIDs	proquest_miscellaneous_1681261696 pubmed_primary_25972001
PublicationCentury	2000
PublicationDate	2015-May-13 20150513
PublicationDateYYYYMMDD	2015-05-13
PublicationDate_xml	– month: 05 year: 2015 text: 2015-May-13 day: 13
PublicationDecade	2010
PublicationPlace	United States
PublicationPlace_xml	– name: United States
PublicationTitle	Science translational medicine
PublicationTitleAlternate	Sci Transl Med
PublicationYear	2015
References	24162058 - Health Phys. 2013 Dec;105(6):540-54 17486113 - Nat Cell Biol. 2007 Jun;9(6):654-9 16418236 - Bioinformatics. 2006 Apr 1;22(7):808-14 21857976 - PLoS One. 2011;6(8):e22988 7713791 - Int J Radiat Oncol Biol Phys. 1995 Mar 30;31(5):1319-39 19996457 - Sci Signal. 2009 Dec 8;2(100):ra81 20506303 - Stem Cells. 2010 Jul;28(7):1186-95 20065678 - Health Phys. 2010 Feb;98(2):160-7 19249651 - Semin Radiat Oncol. 2009 Apr;19(2):133-9 18491294 - Curr Protoc Immunol. 2008 May;Chapter 15:Unit 15.21 14633795 - Hematology Am Soc Hematol Educ Program. 2003;:473-96 21271940 - Int J Radiat Biol. 2011 Jul;87(7):653-62 17933679 - Drug Discov Today. 2007 Oct;12(19-20):794-805 25170040 - J Am Osteopath Assoc. 2014 Sep;114(9):702-11 23036329 - Methods. 2013 Jan;59(1):S1-6 18663219 - Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10513-8 17993851 - Health Phys. 2007 Dec;93(6):701-4 15197022 - Ann Intern Med. 2004 Jun 15;140(12):1037-51 17909684 - Singapore Med J. 2007 Oct;48(10):950-7 24046777 - Front Genet. 2013 Sep 05;4:173 15879151 - J Immunol. 2005 May 15;174(10):6477-89 21423178 - Nat Cell Biol. 2011 Apr;13(4):423-33 17095624 - Blood. 2007 Mar 15;109(6):2365-72 2901866 - Blood. 1988 Oct;72(4):1193-6 15118152 - Science. 2004 Apr 30;304(5671):693-4 9119674 - Health Phys. 1997 Apr;72(4):513-8 23561934 - Comp Med. 2013 Feb;63(1):22-8 24622326 - Blood. 2014 May 15;123(20):3105-15 12520465 - Semin Radiat Oncol. 2003 Jan;13(1):62-72 22424228 - Cell. 2012 Mar 16;148(6):1172-87 22330228 - BMC Res Notes. 2012 Feb 13;5:92 21383194 - Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):5003-8 24973947 - Nat Methods. 2014 Aug;11(8):809-15 19399682 - Int J Radiat Biol. 2009 Apr;85(4):369-76 16150936 - Blood. 2006 Jan 1;107(1):358-66 20617329 - Radiat Environ Biophys. 2010 Nov;49(4):567-81 23451251 - PLoS One. 2013;8(2):e57603 21647195 - Nat Rev Clin Oncol. 2011 Aug;8(8):467-77
References_xml	– reference: 25170040 - J Am Osteopath Assoc. 2014 Sep;114(9):702-11 – reference: 21271940 - Int J Radiat Biol. 2011 Jul;87(7):653-62 – reference: 20617329 - Radiat Environ Biophys. 2010 Nov;49(4):567-81 – reference: 23561934 - Comp Med. 2013 Feb;63(1):22-8 – reference: 14633795 - Hematology Am Soc Hematol Educ Program. 2003;:473-96 – reference: 7713791 - Int J Radiat Oncol Biol Phys. 1995 Mar 30;31(5):1319-39 – reference: 21423178 - Nat Cell Biol. 2011 Apr;13(4):423-33 – reference: 24046777 - Front Genet. 2013 Sep 05;4:173 – reference: 17933679 - Drug Discov Today. 2007 Oct;12(19-20):794-805 – reference: 18491294 - Curr Protoc Immunol. 2008 May;Chapter 15:Unit 15.21 – reference: 20506303 - Stem Cells. 2010 Jul;28(7):1186-95 – reference: 17095624 - Blood. 2007 Mar 15;109(6):2365-72 – reference: 16418236 - Bioinformatics. 2006 Apr 1;22(7):808-14 – reference: 21857976 - PLoS One. 2011;6(8):e22988 – reference: 15118152 - Science. 2004 Apr 30;304(5671):693-4 – reference: 24973947 - Nat Methods. 2014 Aug;11(8):809-15 – reference: 22330228 - BMC Res Notes. 2012 Feb 13;5:92 – reference: 24622326 - Blood. 2014 May 15;123(20):3105-15 – reference: 15197022 - Ann Intern Med. 2004 Jun 15;140(12):1037-51 – reference: 15879151 - J Immunol. 2005 May 15;174(10):6477-89 – reference: 19399682 - Int J Radiat Biol. 2009 Apr;85(4):369-76 – reference: 20065678 - Health Phys. 2010 Feb;98(2):160-7 – reference: 18663219 - Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10513-8 – reference: 17486113 - Nat Cell Biol. 2007 Jun;9(6):654-9 – reference: 17909684 - Singapore Med J. 2007 Oct;48(10):950-7 – reference: 12520465 - Semin Radiat Oncol. 2003 Jan;13(1):62-72 – reference: 16150936 - Blood. 2006 Jan 1;107(1):358-66 – reference: 19996457 - Sci Signal. 2009 Dec 8;2(100):ra81 – reference: 19249651 - Semin Radiat Oncol. 2009 Apr;19(2):133-9 – reference: 17993851 - Health Phys. 2007 Dec;93(6):701-4 – reference: 21647195 - Nat Rev Clin Oncol. 2011 Aug;8(8):467-77 – reference: 2901866 - Blood. 1988 Oct;72(4):1193-6 – reference: 21383194 - Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):5003-8 – reference: 24162058 - Health Phys. 2013 Dec;105(6):540-54 – reference: 9119674 - Health Phys. 1997 Apr;72(4):513-8 – reference: 23451251 - PLoS One. 2013;8(2):e57603 – reference: 22424228 - Cell. 2012 Mar 16;148(6):1172-87 – reference: 23036329 - Methods. 2013 Jan;59(1):S1-6
SSID	ssj0068356
Score	2.4461987
Snippet	Accidental radiation exposure is a threat to human health that necessitates effective clinical planning and diagnosis. Minimally invasive biomarkers that can...
SourceID	proquest pubmed
SourceType	Aggregation Database Index Database
StartPage	287ra69
SubjectTerms	Animals Biomarkers - blood Gene Expression Profiling Hematopoietic Stem Cells - radiation effects Humans Male Mice Mice, Inbred C57BL MicroRNAs - blood MicroRNAs - genetics Whole-Body Irradiation
Title	Serum microRNAs are early indicators of survival after radiation-induced hematopoietic injury
URI	https://www.ncbi.nlm.nih.gov/pubmed/25972001 https://www.proquest.com/docview/1681261696
Volume	7
WOSCitedRecordID	wos000354433900003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings	1
isFullTextHit
isPrint
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF7Uinjx_agvVvAa7WY3m-xJilg82FBEoRcJ-wpUbFKb1t_vTJrqSRA8JOSwS8LOZObb_eZByJV3HaOsxTg_LgKBT0ZELuAajxmUBwReS_oxTtNkOFSD5sCtasIqlzaxNtSutHhGfsOwUJZkUsnbyUeAXaOQXW1aaKySFgcog1odD79ZBAlvq7OLlJAB5kE0qXNN0swMncE7-JxrrbWMkHr-DWTWzqa3_d_P3CFbDcyk3YVe7JIVX-yRjX5DpO-TV7AR8zEdYzjeU9qtqJ566rHYMUUS2-JWvKJlTqs52BLQRlo3E6dTLGWAsgxgGGiFo3XR13JSjjAbEia_gZAOyEvv_vnuIWg6LQRWxGIW2MjkiWWh5WFHg43MO847ZrgAOTIJuxZtjeNGOW28iJQxllkROuWiUHqV6PCQrBVl4Y8JZTFXOgGvbzUHqCW00zKBS8cGoA_nbXK5XLgMNBnpCV34cl5lP0vXJkeL1c8mi5IbGWzSYoz-OvnD7FOyCagmQoqf8TPSyuE_9udk3X7ORtX0olYRuKeD_hf5islz
linkProvider	ProQuest
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serum+microRNAs+are+early+indicators+of+survival+after+radiation-induced+hematopoietic+injury&rft.jtitle=Science+translational+medicine&rft.au=Acharya%2C+Sanket+S&rft.au=Fendler%2C+Wojciech&rft.au=Watson%2C+Jacqueline&rft.au=Hamilton%2C+Abigail&rft.date=2015-05-13&rft.eissn=1946-6242&rft.volume=7&rft.issue=287&rft.spage=287ra69&rft_id=info:doi/10.1126%2Fscitranslmed.aaa6593&rft_id=info%3Apmid%2F25972001&rft_id=info%3Apmid%2F25972001&rft.externalDocID=25972001
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1946-6242&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1946-6242&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1946-6242&client=summon